Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

PATENT FLASH

Nov. 8, 1991

NEORX DOUBLES COMMON STOCK

Nov. 8, 1991

MYCOGEN COMPLETES OFFERING

Nov. 8, 1991

SEPSIS MORTALITY DROPS IN ANTRIL TRIALS

Nov. 8, 1991

BTGC FINDS UNIQUE HIV TARGET

Nov. 8, 1991

ATHENA INCREASES SHARES IN OFFERING

Nov. 8, 1991

GREENWICH RAISES $15M IN PRIVATE PLACEMENT

Nov. 8, 1991

EMBREX IPO TO RAISE $16.4 MILLION

Nov. 8, 1991

MEDIMMUNE INVESTORS SELL SHARES

Nov. 8, 1991

POSSIBLE HEPATITIS VACCINE REACTIONS

Nov. 8, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...